,22 Specifically, BRD4 was shown to maintain the active form of NF-κB in tumors,23 while BET inhibition broadly sensitized diverse tumor cell lines to the cytotoxic activity of TNF, involving the suppression of pro-survival NF-κB transcription.23 The gene discussed is TNF; the disease is neoplasm.